August 19 (SeeNews) - Croatian pharmaceuticals producer Jadran Galenski Laboratorij [ZSE:3JDG2] said on Friday it consolidated EBITDA reached 100.4 million kuna ($13.4 million/13.4 million euro) in the first half of this year from 33.2 million kuna in the same period of last year.